オピオイドの世界市場レポート 2025

オピオイドの市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR3.3％で276億2,000万米ドルに成長します。予測期間の成長は、非がん性疼痛の適応、規制の変更、遠隔医療と遠隔処方、慢性疼痛管理に起因すると考えられます。予測期間の主な動向には、オピオイド温存戦略、薬物療法支援（MAT）、リスク軽減、公衆衛生への取り組みなどがあります。

外科手術の増加は、当面のオピオイド市場拡大の原動力となります。外科的処置は、特殊な道具を用いた切開を伴う医療介入を包含し、通常、手術室のような管理された環境で行われ、多くの場合、麻酔や呼吸補助の使用を必要とします。オピオイドは、疼痛管理のために外科手術中に重要な役割を果たし、麻酔の補助として、あるいは主要な麻酔薬として機能することもあります。例えば、2023年8月、フランスに本部を置く政府間組織である経済協力開発機構のデータによると、チェコ共和国では白内障手術の総数が8.4％増加し、2021年の131,612件から2022年には142,670件に増加しました。さらに、トルコにおける鼠径ヘルニアの腹腔鏡手術件数は35.2％急増し、2021年の18,739件から2022年には25,348件に達しました。したがって、外科手術の増加は、オピオイド市場を推進する態勢を整えています。

慢性疾患の急増は、急成長するオピオイド市場の極めて重要な促進要因になると予想されます。慢性疾患は非感染性疾患（NCDs）とも呼ばれ、徐々に進行し、長期化することを特徴とする持続的な病状を包括しています。これらの疾患は一般的に長期間にわたり持続し、自然治癒することなく何年も、あるいは生涯を通じて持続することが多いです。慢性疾患の急増は、オピオイド市場の中心的な要素です。慢性疾患や慢性疼痛に苦しむ人口の増加に伴い、オピオイドの需要は増加傾向にあります。慢性疾患管理におけるオピオイドの利用は、ヘルスケアにおいてダイナミックに進化しており、疼痛緩和に有効であることで知られています。例えば、スイスに本部を置く健康問題の専門機関である世界保健機関（WHO）によると、慢性疾患は世界的に大きな負担となっており、毎年4,100万人が死亡し、死亡者全体の74％を占めています。これらの慢性疾患のうち、心血管疾患は1,790万人、がんは930万人、慢性呼吸器疾患は410万人、糖尿病は200万人の死亡原因となっています。その結果、慢性疾患の有病率の上昇がオピオイド市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界オピオイド PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のオピオイド市場：成長率分析
• 世界のオピオイド市場の実績：規模と成長, 2019-2024
• 世界のオピオイド市場の予測：規模と成長, 2024-2029, 2034F
• 世界オピオイド総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のオピオイド市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• メサドン
• コデイン
• フェンタニル
• オキシコドン
• モルヒネ
• ヒドロコドン
• その他の製品タイプ
• 世界のオピオイド市場受容体結合による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 強力なアゴニスト
• 軽度から中等度のアゴニスト
• 世界のオピオイド市場適応基準による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 炎症性疾患
• 筋骨格系の痛み
• 神経障害性疼痛
• がんの痛み
• 世界のオピオイド市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 小売薬局
• オンライン薬局
• 世界のオピオイド市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疼痛管理
• 咳の治療
• 下痢の治療
• 世界のオピオイド市場、メサドンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• メサドン錠
• メサドン経口液
• 世界のオピオイド市場、コデインのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コデインリン酸錠
• コデイン液剤
• 世界のオピオイド市場フェンタニルの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• フェンタニルパッチ
• フェンタニル注射
• フェンタニル舌下錠
• 世界のオピオイド市場、オキシコドンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オキシコドン錠
• オキシコドン徐放性製剤
• 世界のオピオイド市場、モルヒネの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• モルヒネ硫酸塩錠
• モルヒネ注射
• モルヒネ徐放性カプセル
• 世界のオピオイド市場、ヒドロコドンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒドロコドン/アセトアミノフェン錠
• ヒドロコドン液剤
• 世界のオピオイド市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブプレノルフィン
• トラマドール
• その他の組み合わせ製品

第7章 地域別・国別分析

• 世界のオピオイド市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のオピオイド市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• オピオイド市場：競合情勢
• オピオイド市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Viatris Inc.
• Teva Pharmaceutical Industries Limited
• Sandoz Inc.
• Sun Pharmaceutical Industries Limited
• Aurobindo Pharma Limited
• Purdue Pharma L.P.
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals plc
• Endo Pharmaceuticals Inc.
• Amneal Pharmaceuticals Inc.
• Mallinckrodt Pharmaceuticals plc
• Alkermes plc
• Lannett Co Inc.
• Par Pharmaceutical Inc.
• Mayne Pharma Group Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• オピオイド市場2029：新たな機会を提供する国
• オピオイド市場2029：新たな機会を提供するセグメント
• オピオイド市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Opioids refer to a class of potent medications derived from the opium poppy plant or synthesized in laboratories. They exert their effects on the nervous system to alleviate pain. Opioids are highly effective in managing moderate to severe pain, including post-surgery pain, cancer-related pain, and chronic pain disorders. They are also used to address issues such as coughing and diarrhea.

The primary types of opioid products include methadone, codeine, fentanyl, oxycodone, morphine, hydrocodone, and others. Methadone is a medication utilized in opioid addiction treatment programs to help individuals reduce or cease their use of heroin or other opioids. Opioids work by binding to various receptors, including strong agonists and mild to moderate agonists, in the nervous system. They are administered for a range of symptoms and indications, including inflammatory conditions, musculoskeletal pain, neuropathic pain, and cancer pain. Opioid medications are available in hospitals, retail pharmacies, and online pharmacies and are used in various medical applications, such as pain management, cough treatment, and diarrhea treatment.

The opioids market research report is one of a series of new reports from The Business Research Company that provides opioids market statistics, including the opioids industry's global market size, regional shares, competitors with an opioids market share, detailed opioids market segments, market trends and opportunities and any further data you may need to thrive in the opioid industry. This opioid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The opioids market size has grown steadily in recent years. It will grow from $23.54 billion in 2024 to $24.22 billion in 2025 at a compound annual growth rate (CAGR) of 2.9%. The growth in the historic period can be attributed to pain management, surgical procedures, palliative care, regulatory environment.

The opioids market size is expected to see steady growth in the next few years. It will grow to $27.62 billion in 2029 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to non-cancer pain indications, regulatory changes, telemedicine and remote prescribing, chronic pain management. Major trends in the forecast period include opioid-sparing strategies, medication-assisted treatment (mat), risk mitigation, public health initiatives.

The escalating number of surgical procedures is poised to act as a driving force behind the expansion of the opioids market in the foreseeable future. Surgical procedures encompass a spectrum of medical interventions involving incisions made with specialized tools, typically performed in controlled environments such as operating rooms, often necessitating the use of anesthesia or respiratory support. Opioids play a vital role during surgical procedures for managing pain and can serve as adjuncts to anesthesia or even as primary anesthetic agents. For instance, in August 2023, data from the Organization for Economic Co-operation and Development, an intergovernmental organization headquartered in France, revealed that the Czech Republic witnessed an 8.4% increase in the total number of cataract surgical procedures, rising from 131,612 procedures in 2021 to 142,670 in 2022. Furthermore, the total count of laparoscopic repairs for inguinal hernia surgical procedures in Turkey surged by 35.2%, reaching 25,348 in 2022 from 18,739 in 2021. Hence, the upswing in surgical procedures is poised to propel the opioids market.

The mounting prevalence of chronic diseases is expected to be a pivotal driver for the burgeoning opioids market. Chronic diseases, also recognized as non-communicable diseases (NCDs), encompass a spectrum of persistent medical conditions characterized by gradual progression and prolonged duration. These ailments typically endure over an extended period, often persisting for years or even throughout a lifetime, without spontaneous resolution. The burgeoning prevalence of chronic diseases constitutes a central element of the opioids market. With a growing population afflicted by chronic ailments and enduring chronic pain, the demand for opioids is on the rise. Opioid utilization within the context of chronic disease management is a dynamic and evolving facet of healthcare, renowned for its effectiveness in pain relief. For example, according to the World Health Organization, an agency specialized in health matters and headquartered in Switzerland, chronic diseases contribute to a substantial global burden, causing 41 million deaths each year, accounting for 74% of all fatalities. Among these chronic diseases, cardiovascular diseases cause 17.9 million deaths, cancer leads to 9.3 million deaths, chronic respiratory diseases result in 4.1 million deaths, and diabetes is responsible for 2.0 million deaths. Consequently, the escalating prevalence of chronic diseases is fostering the growth of the opioids market.

Prominent companies operating in the opioid market are dedicated to pioneering advanced pharmaceutical solutions to strengthen their market position. The development of novel medications holds the potential to treat diseases, elevate healthcare standards, and contribute to scientific knowledge. For instance, in May 2023, Braeburn Pharmaceuticals Inc., a U.S.-based provider of solutions for opioid addiction treatment, announced the U.S. Food and Drug Administration's approval of Brixadi (buprenorphine) extended-release subcutaneous injection for the management of moderate to severe opioid use disorder (OUD). This marks the first and only weekly and monthly subcutaneous injection for moderate to severe OUD, employing the innovative FluidCrystal Injection Depot Technology. The prescription recommendations allow patients receiving oral buprenorphine-containing medications to transition to equivalent dosages if followed.

In March 2023, Indivior PLC, a U.S.-based specialty pharmaceuticals company, acquired Opiant Pharmaceuticals Inc. for $145 million. This acquisition empowers Indivior to establish a comprehensive and relevant treatment platform to address the ongoing opioid and overdose crisis in the United States. It bolsters Indivior's addiction treatment and scientific portfolio by incorporating Opiant's late-stage assets, particularly OPNT003. Opiant Pharmaceuticals Inc. is a U.S.-based developer of therapies designed to combat opioid drug overdose and addiction.

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca PLC, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals PLC, Alkermes PLC, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

North America was the largest region in the opioids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in opioids report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the opioids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The opioids market consists of sales of oxycodone (OxyContin), hydrocodone (Vicodin), morphine and methadone. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Opioids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on opioids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for opioids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The opioids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Methadone; Codeine; Fentanyl; Oxycodone; Morphine; Hydrocodone; Other Product Types
• 2) By Receptor Binding: Strong Agonist; Mild To Moderate Agonist
• 3) By Basis Of Indication: Inflammatory Condition; Musculoskeletal Pain; Neuropathic Pain; Cancer Pain
• 4) By Distribution Channel: Hospital; Retail Pharmacies; Online Pharmacies
• 5) By Application: Pain Management; Cough Treatment; Diarrhea Treatment
• Subsegments:
• 1) By Methadone: Methadone Tablets; Methadone Oral Solution
• 2) By Codeine: Codeine Phosphate Tablets; Codeine Liquid Formulations
• 3) By Fentanyl: Fentanyl Patch; Fentanyl Injection; Fentanyl Sublingual Tablets
• 4) By Oxycodone: Oxycodone Tablets; Oxycodone Extended-Release Formulations
• 5) By Morphine: Morphine Sulfate Tablets; Morphine Injection; Morphine Extended-Release Capsules
• 6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets; Hydrocodone Liquid Formulations
• 7) By Other Product Types: Buprenorphine; Tramadol; Other Combination Products
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc.; AbbVie Inc.; Sanofi S.A; AstraZeneca Plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Opioids Market Characteristics

3. Opioids Market Trends And Strategies

4. Opioids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Opioids Growth Analysis And Strategic Analysis Framework

• 5.1. Global Opioids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Opioids Market Growth Rate Analysis
• 5.4. Global Opioids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Opioids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Opioids Total Addressable Market (TAM)

6. Opioids Market Segmentation

• 6.1. Global Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Methadone
• Codeine
• Fentanyl
• Oxycodone
• Morphine
• Hydrocodone
• Other Product Types
• 6.2. Global Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Strong Agonist
• Mild To Moderate Agonist
• 6.3. Global Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inflammatory Condition
• Musculoskeletal Pain
• Neuropathic Pain
• Cancer Pain
• 6.4. Global Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Opioids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Cough Treatment
• Diarrhea Treatment
• 6.6. Global Opioids Market, Sub-Segmentation Of Methadone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Methadone Tablets
• Methadone Oral Solution
• 6.7. Global Opioids Market, Sub-Segmentation Of Codeine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Codeine Phosphate Tablets
• Codeine Liquid Formulations
• 6.8. Global Opioids Market, Sub-Segmentation Of Fentanyl, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fentanyl Patch
• Fentanyl Injection
• Fentanyl Sublingual Tablets
• 6.9. Global Opioids Market, Sub-Segmentation Of Oxycodone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oxycodone Tablets
• Oxycodone Extended-Release Formulations
• 6.10. Global Opioids Market, Sub-Segmentation Of Morphine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Morphine Sulfate Tablets
• Morphine Injection
• Morphine Extended-Release Capsules
• 6.11. Global Opioids Market, Sub-Segmentation Of Hydrocodone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrocodone/Acetaminophen Tablets
• Hydrocodone Liquid Formulations
• 6.12. Global Opioids Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buprenorphine
• Tramadol
• Other Combination Products

7. Opioids Market Regional And Country Analysis

• 7.1. Global Opioids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Opioids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Opioids Market

• 8.1. Asia-Pacific Opioids Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Opioids Market

• 9.1. China Opioids Market Overview
• 9.2. China Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Opioids Market

• 10.1. India Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Opioids Market

• 11.1. Japan Opioids Market Overview
• 11.2. Japan Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Opioids Market

• 12.1. Australia Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Opioids Market

• 13.1. Indonesia Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Opioids Market

• 14.1. South Korea Opioids Market Overview
• 14.2. South Korea Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Opioids Market

• 15.1. Western Europe Opioids Market Overview
• 15.2. Western Europe Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Opioids Market

• 16.1. UK Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Opioids Market

• 17.1. Germany Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Opioids Market

• 18.1. France Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Opioids Market

• 19.1. Italy Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Opioids Market

• 20.1. Spain Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Opioids Market

• 21.1. Eastern Europe Opioids Market Overview
• 21.2. Eastern Europe Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Opioids Market

• 22.1. Russia Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Opioids Market

• 23.1. North America Opioids Market Overview
• 23.2. North America Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Opioids Market

• 24.1. USA Opioids Market Overview
• 24.2. USA Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Opioids Market

• 25.1. Canada Opioids Market Overview
• 25.2. Canada Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Opioids Market

• 26.1. South America Opioids Market Overview
• 26.2. South America Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Opioids Market

• 27.1. Brazil Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Opioids Market

• 28.1. Middle East Opioids Market Overview
• 28.2. Middle East Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Opioids Market

• 29.1. Africa Opioids Market Overview
• 29.2. Africa Opioids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Opioids Market Competitive Landscape And Company Profiles

• 30.1. Opioids Market Competitive Landscape
• 30.2. Opioids Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

31. Opioids Market Other Major And Innovative Companies

• 31.1. Viatris Inc.
• 31.2. Teva Pharmaceutical Industries Limited
• 31.3. Sandoz Inc.
• 31.4. Sun Pharmaceutical Industries Limited
• 31.5. Aurobindo Pharma Limited
• 31.6. Purdue Pharma L.P.
• 31.7. Dr. Reddy's Laboratories Ltd.
• 31.8. Hikma Pharmaceuticals plc
• 31.9. Endo Pharmaceuticals Inc.
• 31.10. Amneal Pharmaceuticals Inc.
• 31.11. Mallinckrodt Pharmaceuticals plc
• 31.12. Alkermes plc
• 31.13. Lannett Co Inc.
• 31.14. Par Pharmaceutical Inc.
• 31.15. Mayne Pharma Group Ltd.

32. Global Opioids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Opioids Market

34. Recent Developments In The Opioids Market

35. Opioids Market High Potential Countries, Segments and Strategies

• 35.1 Opioids Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Opioids Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Opioids Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer